Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
Sign Up to like & getrecommendations! Published in 2017 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-017-3624-y
Abstract: PurposeTo evaluate the visual and anatomical outcomes following switching therapy from bevacizumab to aflibercept in patients with persistent diabetic macular edema (DME).MethodsPatients with DME and central macular thickness (CMT) >300 μm on spectral domain optical coherence… read more here.
Keywords: bevacizumab aflibercept; bevacizumab; diabetic macular; switching therapy ... See more keywords
Cefpodoxime proxetil as a therapeutic option in switching therapy for infective endocarditis in children: case reports and literature review
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Chemotherapy"
DOI: 10.1080/1120009x.2019.1603797
Abstract: Infective endocarditis (IE) is uncommon in children, affecting predominantly subjects with congenital heart disease (CHD) and patients with indwelling central lines. The principles of antibiotic treatment in paediatric population are similar to those in adults.… read more here.
Keywords: switching therapy; therapy; infective endocarditis; cefpodoxime proxetil ... See more keywords
Splice-Switching Therapy for Spinal Muscular Atrophy
Sign Up to like & getrecommendations! Published in 2017 at "Genes"
DOI: 10.3390/genes8060161
Abstract: Spinal muscular atrophy (SMA) is a genetic disorder with severity ranging from premature death in infants to restricted motor function in adult life. Despite the genetic cause of this disease being known for over twenty… read more here.
Keywords: spinal muscular; switching therapy; splice switching; muscular atrophy ... See more keywords